0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Wearable Injectors Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-18D3116
Home | Market Reports | Health| Medical Devices & Equipment
Global Wearable Injectors Market Insights and Forecast to 2028
BUY CHAPTERS

Wearable Injectors Market Insights and Forecast to 2028

Code: QYRE-Auto-18D3116
Report
January 2022
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Wearable Injectors Market Outlook - 2028

Due to the COVID-19 pandemic, the global Wearable Injectors market size is estimated to be worth USD 3246.5 million in 2022 and is forecast to a readjusted size of USD 4982.4 million by 2028 with a CAGR of 7.4% during the review period.

Wearable Injectors Market

Fully considering the economic change by this health crisis, Electronical Injectors accounting for % of the Wearable Injectors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Cancer segment is altered to an % CAGR throughout this forecast period.

Wearable Injectors Market Insights

China Wearable Injectors market size is valued at US$ million in 2021, while the US and Europe Wearable Injectors are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Wearable Injectors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Wearable Injectors include Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed and Ypsomed Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Wearable Injectors Market Scope and Segment

Wearable Injectors market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Wearable Injectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Electronical Injectors
  • Mechanical Injectors
  • Others

Segment by Application

  • Cancer
  • Infectious Disease
  • Autoimmune Disorder
  • Cardiovascular Disease
  • Blood Disorder
  • Others

By Company

  • Becton
  • Dickinson and Company
  • Medtronic
  • Johnson & Johnson
  • Insulet Corporation
  • Unilife Corporation
  • Enable Injections
  • SteadyMed
  • Ypsomed Group
  • West Pharmaceutical Services
  • Unilife
  • CeQur
  • Sensile Medical
  • BD Medical
  • Roche
  • ScPharmaceuticals
  • SteadyMed
  • J & J

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Wearable Injectors Market Report Coverage

Report Metric

Details

Base Year:

2021

Market Size in 2022:

USD 3246.5 Million

Forecast Period:

2022 to 2028

Forecast Period 2023 to 2028 CAGR:

7.4%

2028 Value Projection:

USD 4982.4 Million

No. of Pages:

111

Tables & Figures

145

Segments covered:

Type, Application, Region

Frequently Asked Questions About This Report

1. What would be the forecast period in the Wearable Injectors Market report?

Ans. The forecast period in the Wearable Injectors Market report is from 2022 to 2028.

2. How can I get chapter-wise report/company profiles of the Global Wearable Injectors industry?

Ans. The Chapter-wise Wearable Injectors market report can be obtained on from the Valuates Reports website. Also, 24*7 chat support and direct call services are provided to procure the chapter-wise report.

3. What are the Segments by type in the Wearable Injectors Market report?

Ans. Electronical Injectors, Mechanical Injectors, Others are the segments by type in Wearable Injectors Market.

4. How big is the Wearable Injectors Market?

Ans. Wearable Injectors market size is estimated to be worth US$ 3246.5 million in 2022 and is forecast to a readjusted size of US$ 4982.4 million by 2028 with a CAGR of 7.4% during the review period.

5. Who are the key players in the Wearable Injectors market?

Ans. Some of the key players are Becton, Dickinson and Company, Medtronic Inc, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group, West Pharmaceutical Services, Unilife, CeQur, Sensile Medical, BD Medical, Roche, ScPharmaceuticals, SteadyMed, J & J, Company, Russia, Others.

1 Study Coverage
1.1 Wearable Injectors Product Introduction
1.2 Market by Type
1.2.1 Global Wearable Injectors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Wearable Injectors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Infectious Disease
1.3.4 Autoimmune Disorder
1.3.5 Cardiovascular Disease
1.3.6 Blood Disorder
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Wearable Injectors Sales Estimates and Forecasts 2017-2028
2.2 Global Wearable Injectors Revenue Estimates and Forecasts 2017-2028
2.3 Global Wearable Injectors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Wearable Injectors Sales by Region
2.4.1 Global Wearable Injectors Sales by Region (2017-2022)
2.4.2 Global Sales Wearable Injectors by Region (2023-2028)
2.5 Global Wearable Injectors Revenue by Region
2.5.1 Global Wearable Injectors Revenue by Region (2017-2022)
2.5.2 Global Wearable Injectors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Wearable Injectors Sales by Manufacturers
3.1.1 Global Top Wearable Injectors Manufacturers by Sales (2017-2022)
3.1.2 Global Wearable Injectors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Wearable Injectors in 2021
3.2 Global Wearable Injectors Revenue by Manufacturers
3.2.1 Global Wearable Injectors Revenue by Manufacturers (2017-2022)
3.2.2 Global Wearable Injectors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Wearable Injectors Revenue in 2021
3.3 Global Wearable Injectors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Wearable Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Wearable Injectors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Wearable Injectors Sales by Type
4.1.1 Global Wearable Injectors Historical Sales by Type (2017-2022)
4.1.2 Global Wearable Injectors Forecasted Sales by Type (2023-2028)
4.1.3 Global Wearable Injectors Sales Market Share by Type (2017-2028)
4.2 Global Wearable Injectors Revenue by Type
4.2.1 Global Wearable Injectors Historical Revenue by Type (2017-2022)
4.2.2 Global Wearable Injectors Forecasted Revenue by Type (2023-2028)
4.2.3 Global Wearable Injectors Revenue Market Share by Type (2017-2028)
4.3 Global Wearable Injectors Price by Type
4.3.1 Global Wearable Injectors Price by Type (2017-2022)
4.3.2 Global Wearable Injectors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Wearable Injectors Sales by Application
5.1.1 Global Wearable Injectors Historical Sales by Application (2017-2022)
5.1.2 Global Wearable Injectors Forecasted Sales by Application (2023-2028)
5.1.3 Global Wearable Injectors Sales Market Share by Application (2017-2028)
5.2 Global Wearable Injectors Revenue by Application
5.2.1 Global Wearable Injectors Historical Revenue by Application (2017-2022)
5.2.2 Global Wearable Injectors Forecasted Revenue by Application (2023-2028)
5.2.3 Global Wearable Injectors Revenue Market Share by Application (2017-2028)
5.3 Global Wearable Injectors Price by Application
5.3.1 Global Wearable Injectors Price by Application (2017-2022)
5.3.2 Global Wearable Injectors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Wearable Injectors Market Size by Type
6.1.1 North America Wearable Injectors Sales by Type (2017-2028)
6.1.2 North America Wearable Injectors Revenue by Type (2017-2028)
6.2 North America Wearable Injectors Market Size by Application
6.2.1 North America Wearable Injectors Sales by Application (2017-2028)
6.2.2 North America Wearable Injectors Revenue by Application (2017-2028)
6.3 North America Wearable Injectors Market Size by Country
6.3.1 North America Wearable Injectors Sales by Country (2017-2028)
6.3.2 North America Wearable Injectors Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Wearable Injectors Market Size by Type
7.1.1 Europe Wearable Injectors Sales by Type (2017-2028)
7.1.2 Europe Wearable Injectors Revenue by Type (2017-2028)
7.2 Europe Wearable Injectors Market Size by Application
7.2.1 Europe Wearable Injectors Sales by Application (2017-2028)
7.2.2 Europe Wearable Injectors Revenue by Application (2017-2028)
7.3 Europe Wearable Injectors Market Size by Country
7.3.1 Europe Wearable Injectors Sales by Country (2017-2028)
7.3.2 Europe Wearable Injectors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Wearable Injectors Market Size by Type
8.1.1 Asia Pacific Wearable Injectors Sales by Type (2017-2028)
8.1.2 Asia Pacific Wearable Injectors Revenue by Type (2017-2028)
8.2 Asia Pacific Wearable Injectors Market Size by Application
8.2.1 Asia Pacific Wearable Injectors Sales by Application (2017-2028)
8.2.2 Asia Pacific Wearable Injectors Revenue by Application (2017-2028)
8.3 Asia Pacific Wearable Injectors Market Size by Region
8.3.1 Asia Pacific Wearable Injectors Sales by Region (2017-2028)
8.3.2 Asia Pacific Wearable Injectors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Wearable Injectors Market Size by Type
9.1.1 Latin America Wearable Injectors Sales by Type (2017-2028)
9.1.2 Latin America Wearable Injectors Revenue by Type (2017-2028)
9.2 Latin America Wearable Injectors Market Size by Application
9.2.1 Latin America Wearable Injectors Sales by Application (2017-2028)
9.2.2 Latin America Wearable Injectors Revenue by Application (2017-2028)
9.3 Latin America Wearable Injectors Market Size by Country
9.3.1 Latin America Wearable Injectors Sales by Country (2017-2028)
9.3.2 Latin America Wearable Injectors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Wearable Injectors Market Size by Type
10.1.1 Middle East and Africa Wearable Injectors Sales by Type (2017-2028)
10.1.2 Middle East and Africa Wearable Injectors Revenue by Type (2017-2028)
10.2 Middle East and Africa Wearable Injectors Market Size by Application
10.2.1 Middle East and Africa Wearable Injectors Sales by Application (2017-2028)
10.2.2 Middle East and Africa Wearable Injectors Revenue by Application (2017-2028)
10.3 Middle East and Africa Wearable Injectors Market Size by Country
10.3.1 Middle East and Africa Wearable Injectors Sales by Country (2017-2028)
10.3.2 Middle East and Africa Wearable Injectors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Becton
11.1.1 Becton Corporation Information
11.1.2 Becton Overview
11.1.3 Becton Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Becton Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Becton Recent Developments
11.2 Dickinson and Company
11.2.1 Dickinson and Company Corporation Information
11.2.2 Dickinson and Company Overview
11.2.3 Dickinson and Company Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Dickinson and Company Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Dickinson and Company Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Overview
11.3.3 Medtronic Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medtronic Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medtronic Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Insulet Corporation
11.5.1 Insulet Corporation Corporation Information
11.5.2 Insulet Corporation Overview
11.5.3 Insulet Corporation Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Insulet Corporation Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Insulet Corporation Recent Developments
11.6 Unilife Corporation
11.6.1 Unilife Corporation Corporation Information
11.6.2 Unilife Corporation Overview
11.6.3 Unilife Corporation Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Unilife Corporation Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Unilife Corporation Recent Developments
11.7 Enable Injections
11.7.1 Enable Injections Corporation Information
11.7.2 Enable Injections Overview
11.7.3 Enable Injections Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Enable Injections Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Enable Injections Recent Developments
11.8 SteadyMed
11.8.1 SteadyMed Corporation Information
11.8.2 SteadyMed Overview
11.8.3 SteadyMed Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 SteadyMed Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 SteadyMed Recent Developments
11.9 Ypsomed Group
11.9.1 Ypsomed Group Corporation Information
11.9.2 Ypsomed Group Overview
11.9.3 Ypsomed Group Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ypsomed Group Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ypsomed Group Recent Developments
11.10 West Pharmaceutical Services
11.10.1 West Pharmaceutical Services Corporation Information
11.10.2 West Pharmaceutical Services Overview
11.10.3 West Pharmaceutical Services Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 West Pharmaceutical Services Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 West Pharmaceutical Services Recent Developments
11.11 Unilife
11.11.1 Unilife Corporation Information
11.11.2 Unilife Overview
11.11.3 Unilife Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Unilife Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Unilife Recent Developments
11.12 CeQur
11.12.1 CeQur Corporation Information
11.12.2 CeQur Overview
11.12.3 CeQur Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CeQur Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CeQur Recent Developments
11.13 Sensile Medical
11.13.1 Sensile Medical Corporation Information
11.13.2 Sensile Medical Overview
11.13.3 Sensile Medical Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sensile Medical Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sensile Medical Recent Developments
11.14 BD Medical
11.14.1 BD Medical Corporation Information
11.14.2 BD Medical Overview
11.14.3 BD Medical Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 BD Medical Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 BD Medical Recent Developments
11.15 Roche
11.15.1 Roche Corporation Information
11.15.2 Roche Overview
11.15.3 Roche Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Roche Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Roche Recent Developments
11.16 ScPharmaceuticals
11.16.1 ScPharmaceuticals Corporation Information
11.16.2 ScPharmaceuticals Overview
11.16.3 ScPharmaceuticals Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 ScPharmaceuticals Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 ScPharmaceuticals Recent Developments
11.17 SteadyMed
11.17.1 SteadyMed Corporation Information
11.17.2 SteadyMed Overview
11.17.3 SteadyMed Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 SteadyMed Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 SteadyMed Recent Developments
11.18 J & J
11.18.1 J & J Corporation Information
11.18.2 J & J Overview
11.18.3 J & J Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 J & J Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 J & J Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Wearable Injectors Industry Chain Analysis
12.2 Wearable Injectors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Wearable Injectors Production Mode & Process
12.4 Wearable Injectors Sales and Marketing
12.4.1 Wearable Injectors Sales Channels
12.4.2 Wearable Injectors Distributors
12.5 Wearable Injectors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Wearable Injectors Industry Trends
13.2 Wearable Injectors Market Drivers
13.3 Wearable Injectors Market Challenges
13.4 Wearable Injectors Market Restraints
14 Key Findings in The Global Wearable Injectors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Wearable Injectors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Electronical Injectors
    Table 3. Major Manufacturers of Mechanical Injectors
    Table 4. Major Manufacturers of Others
    Table 5. Global Wearable Injectors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Wearable Injectors Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Wearable Injectors Sales by Region (2017-2022) & (K Units)
    Table 8. Global Wearable Injectors Sales Market Share by Region (2017-2022)
    Table 9. Global Wearable Injectors Sales by Region (2023-2028) & (K Units)
    Table 10. Global Wearable Injectors Sales Market Share by Region (2023-2028)
    Table 11. Global Wearable Injectors Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Wearable Injectors Revenue Market Share by Region (2017-2022)
    Table 13. Global Wearable Injectors Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Wearable Injectors Revenue Market Share by Region (2023-2028)
    Table 15. Global Wearable Injectors Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Wearable Injectors Sales Share by Manufacturers (2017-2022)
    Table 17. Global Wearable Injectors Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Wearable Injectors Revenue Share by Manufacturers (2017-2022)
    Table 19. Wearable Injectors Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Wearable Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Wearable Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Injectors as of 2021)
    Table 22. Wearable Injectors Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Wearable Injectors Product Offered
    Table 24. Date of Manufacturers Enter into Wearable Injectors Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Wearable Injectors Sales by Type (2017-2022) & (K Units)
    Table 27. Global Wearable Injectors Sales by Type (2023-2028) & (K Units)
    Table 28. Global Wearable Injectors Sales Share by Type (2017-2022)
    Table 29. Global Wearable Injectors Sales Share by Type (2023-2028)
    Table 30. Global Wearable Injectors Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Wearable Injectors Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Wearable Injectors Revenue Share by Type (2017-2022)
    Table 33. Global Wearable Injectors Revenue Share by Type (2023-2028)
    Table 34. Wearable Injectors Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Wearable Injectors Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Wearable Injectors Sales by Application (2017-2022) & (K Units)
    Table 37. Global Wearable Injectors Sales by Application (2023-2028) & (K Units)
    Table 38. Global Wearable Injectors Sales Share by Application (2017-2022)
    Table 39. Global Wearable Injectors Sales Share by Application (2023-2028)
    Table 40. Global Wearable Injectors Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Wearable Injectors Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Wearable Injectors Revenue Share by Application (2017-2022)
    Table 43. Global Wearable Injectors Revenue Share by Application (2023-2028)
    Table 44. Wearable Injectors Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Wearable Injectors Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Wearable Injectors Sales by Type (2017-2022) & (K Units)
    Table 47. North America Wearable Injectors Sales by Type (2023-2028) & (K Units)
    Table 48. North America Wearable Injectors Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Wearable Injectors Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Wearable Injectors Sales by Application (2017-2022) & (K Units)
    Table 51. North America Wearable Injectors Sales by Application (2023-2028) & (K Units)
    Table 52. North America Wearable Injectors Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Wearable Injectors Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Wearable Injectors Sales by Country (2017-2022) & (K Units)
    Table 55. North America Wearable Injectors Sales by Country (2023-2028) & (K Units)
    Table 56. North America Wearable Injectors Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Wearable Injectors Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Wearable Injectors Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Wearable Injectors Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Wearable Injectors Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Wearable Injectors Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Wearable Injectors Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Wearable Injectors Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Wearable Injectors Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Wearable Injectors Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Wearable Injectors Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Wearable Injectors Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Wearable Injectors Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Wearable Injectors Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Wearable Injectors Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Wearable Injectors Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Wearable Injectors Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Wearable Injectors Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Wearable Injectors Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Wearable Injectors Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Wearable Injectors Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Wearable Injectors Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Wearable Injectors Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Wearable Injectors Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Wearable Injectors Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Wearable Injectors Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Wearable Injectors Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Wearable Injectors Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Wearable Injectors Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Wearable Injectors Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Wearable Injectors Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Wearable Injectors Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Wearable Injectors Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Wearable Injectors Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Wearable Injectors Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Wearable Injectors Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Wearable Injectors Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Wearable Injectors Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Wearable Injectors Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Wearable Injectors Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Wearable Injectors Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Wearable Injectors Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Wearable Injectors Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Wearable Injectors Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Wearable Injectors Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Wearable Injectors Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Wearable Injectors Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Wearable Injectors Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Wearable Injectors Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Wearable Injectors Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Becton Corporation Information
    Table 107. Becton Description and Major Businesses
    Table 108. Becton Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Becton Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Becton Recent Developments
    Table 111. Dickinson and Company Corporation Information
    Table 112. Dickinson and Company Description and Major Businesses
    Table 113. Dickinson and Company Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Dickinson and Company Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Dickinson and Company Recent Developments
    Table 116. Medtronic Corporation Information
    Table 117. Medtronic Description and Major Businesses
    Table 118. Medtronic Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Medtronic Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Medtronic Recent Developments
    Table 121. Johnson & Johnson Corporation Information
    Table 122. Johnson & Johnson Description and Major Businesses
    Table 123. Johnson & Johnson Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Johnson & Johnson Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Johnson & Johnson Recent Developments
    Table 126. Insulet Corporation Corporation Information
    Table 127. Insulet Corporation Description and Major Businesses
    Table 128. Insulet Corporation Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Insulet Corporation Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Insulet Corporation Recent Developments
    Table 131. Unilife Corporation Corporation Information
    Table 132. Unilife Corporation Description and Major Businesses
    Table 133. Unilife Corporation Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Unilife Corporation Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Unilife Corporation Recent Developments
    Table 136. Enable Injections Corporation Information
    Table 137. Enable Injections Description and Major Businesses
    Table 138. Enable Injections Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Enable Injections Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Enable Injections Recent Developments
    Table 141. SteadyMed Corporation Information
    Table 142. SteadyMed Description and Major Businesses
    Table 143. SteadyMed Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. SteadyMed Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. SteadyMed Recent Developments
    Table 146. Ypsomed Group Corporation Information
    Table 147. Ypsomed Group Description and Major Businesses
    Table 148. Ypsomed Group Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Ypsomed Group Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Ypsomed Group Recent Developments
    Table 151. West Pharmaceutical Services Corporation Information
    Table 152. West Pharmaceutical Services Description and Major Businesses
    Table 153. West Pharmaceutical Services Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. West Pharmaceutical Services Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. West Pharmaceutical Services Recent Developments
    Table 156. Unilife Corporation Information
    Table 157. Unilife Description and Major Businesses
    Table 158. Unilife Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Unilife Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Unilife Recent Developments
    Table 161. CeQur Corporation Information
    Table 162. CeQur Description and Major Businesses
    Table 163. CeQur Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 164. CeQur Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. CeQur Recent Developments
    Table 166. Sensile Medical Corporation Information
    Table 167. Sensile Medical Description and Major Businesses
    Table 168. Sensile Medical Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 169. Sensile Medical Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Sensile Medical Recent Developments
    Table 171. BD Medical Corporation Information
    Table 172. BD Medical Description and Major Businesses
    Table 173. BD Medical Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 174. BD Medical Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. BD Medical Recent Developments
    Table 176. Roche Corporation Information
    Table 177. Roche Description and Major Businesses
    Table 178. Roche Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 179. Roche Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 180. Roche Recent Developments
    Table 181. ScPharmaceuticals Corporation Information
    Table 182. ScPharmaceuticals Description and Major Businesses
    Table 183. ScPharmaceuticals Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 184. ScPharmaceuticals Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 185. ScPharmaceuticals Recent Developments
    Table 186. SteadyMed Corporation Information
    Table 187. SteadyMed Description and Major Businesses
    Table 188. SteadyMed Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 189. SteadyMed Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 190. SteadyMed Recent Developments
    Table 191. J & J Corporation Information
    Table 192. J & J Description and Major Businesses
    Table 193. J & J Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 194. J & J Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 195. J & J Recent Developments
    Table 196. Key Raw Materials Lists
    Table 197. Raw Materials Key Suppliers Lists
    Table 198. Wearable Injectors Distributors List
    Table 199. Wearable Injectors Customers List
    Table 200. Wearable Injectors Market Trends
    Table 201. Wearable Injectors Market Drivers
    Table 202. Wearable Injectors Market Challenges
    Table 203. Wearable Injectors Market Restraints
    Table 204. Research Programs/Design for This Report
    Table 205. Key Data Information from Secondary Sources
    Table 206. Key Data Information from Primary Sources
List of Figures
    Figure 1. Wearable Injectors Product Picture
    Figure 3. Global Wearable Injectors Market Share by Type in 2021 & 2028
    Figure 3. Electronical Injectors Product Picture
    Figure 4. Mechanical Injectors Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Wearable Injectors Market Share by Application in 2021 & 2028
    Figure 7. Cancer
    Figure 8. Infectious Disease
    Figure 9. Autoimmune Disorder
    Figure 10. Cardiovascular Disease
    Figure 11. Blood Disorder
    Figure 12. Others
    Figure 13. Wearable Injectors Report Years Considered
    Figure 14. Global Wearable Injectors Sales 2017-2028 (K Units)
    Figure 15. Global Wearable Injectors Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Wearable Injectors Revenue 2017-2028 (US$ Million)
    Figure 17. Global Wearable Injectors Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Wearable Injectors Sales Market Share by Region (2017-2022)
    Figure 19. Global Wearable Injectors Sales Market Share by Region (2023-2028)
    Figure 20. North America Wearable Injectors Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Wearable Injectors Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Wearable Injectors Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Wearable Injectors Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Wearable Injectors Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Wearable Injectors Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Wearable Injectors Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Wearable Injectors Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Wearable Injectors Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Wearable Injectors Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Wearable Injectors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Wearable Injectors in the World: Market Share by Wearable Injectors Revenue in 2021
    Figure 32. Global Wearable Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Wearable Injectors Sales Market Share by Type (2017-2028)
    Figure 34. Global Wearable Injectors Revenue Market Share by Type (2017-2028)
    Figure 35. Global Wearable Injectors Sales Market Share by Application (2017-2028)
    Figure 36. Global Wearable Injectors Revenue Market Share by Application (2017-2028)
    Figure 37. North America Wearable Injectors Sales Market Share by Type (2017-2028)
    Figure 38. North America Wearable Injectors Revenue Market Share by Type (2017-2028)
    Figure 39. North America Wearable Injectors Sales Market Share by Application (2017-2028)
    Figure 40. North America Wearable Injectors Revenue Market Share by Application (2017-2028)
    Figure 41. North America Wearable Injectors Sales Share by Country (2017-2028)
    Figure 42. North America Wearable Injectors Revenue Share by Country (2017-2028)
    Figure 43. U.S. Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Wearable Injectors Sales Market Share by Type (2017-2028)
    Figure 46. Europe Wearable Injectors Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Wearable Injectors Sales Market Share by Application (2017-2028)
    Figure 48. Europe Wearable Injectors Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Wearable Injectors Sales Share by Country (2017-2028)
    Figure 50. Europe Wearable Injectors Revenue Share by Country (2017-2028)
    Figure 51. Germany Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 52. France Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Wearable Injectors Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Wearable Injectors Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Wearable Injectors Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Wearable Injectors Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Wearable Injectors Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Wearable Injectors Revenue Share by Region (2017-2028)
    Figure 62. China Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 65. India Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 67. China Taiwan Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Wearable Injectors Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Wearable Injectors Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Wearable Injectors Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Wearable Injectors Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Wearable Injectors Sales Share by Country (2017-2028)
    Figure 76. Latin America Wearable Injectors Revenue Share by Country (2017-2028)
    Figure 77. Mexico Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Wearable Injectors Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Wearable Injectors Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Wearable Injectors Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Wearable Injectors Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Wearable Injectors Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Wearable Injectors Revenue Share by Country (2017-2028)
    Figure 86. Turkey Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Wearable Injectors Revenue (2017-2028) & (US$ Million)
    Figure 89. Wearable Injectors Value Chain
    Figure 90. Wearable Injectors Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global PET Scan Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4Z8672
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Cell Expansion Disposable Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14V8437
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Microtest Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32R8350
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Tissue Slicer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26U3291
Wed Apr 17 00:00:00 UTC 2024

Add to Cart